Approved Hospital Formulary
QR Code Add Formweb to your mobile device

Formulary synchronization in progress.
Please refer to Epic and your local pharmacy for available medications.

Approved Hospital Formulary
Search results for:

rasburicase

rasburicase
Brand names: Elitek
Form Strength
POWDER FOR INJECTION, INTRAVENOUS 1.5 mg; 7.5 mg


 

Policies and procedures

Policy and Procedure System_RXCLIN 107 Rasburicase Fixed-Dose Policy

Key Points:

  • Rasburicase is limited to a single, fixed dose for prophylaxis or treatment of hyperuricemia based on the following parameters:
    • Uric acid level < 15 mg/dL - single dose not to exceed 3 mg
    • Uric acid level > 15 mg/dL - single dose not to exceed 7.5 mg
  • Pharmacist may round dose in accordance with the parameters above "per policy"
  • A second dose may be administered if hyperuricemia persists after 24 hours in accordance with the parameters above
  • Uric acid levels should be monitored at baseline, 4 hours after administration, and then every 6-8 hours until tumor lysis syndrome resolution "per policy"
  • Order verifying pharmacist shall notify the pharmacy clinical specialist of rasburicase orders not in accordance with this policy

 

Consults, protocols, and therapeutic interchanges

 

Additional information

 

 

 


Last updated: Aug. 9, 2024


This site is intended for the staff of Houston Methodist.
While others may view accessible pages, Houston Methodist makes no warranty, express or implied,
as to the use of this information outside of Houston Methodist.